Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications
Mismatched Unrelated vs Matched Related Donor Transplant With Posttransplant Cyclophosphamide Among Patients With Blood Cancers.
Journal: JAMA network open
Published: July 20, 2026
Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease.
Journal: Transplantation and cellular therapy
Published: July 08, 2026
Phenotype-Specific Associations Between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes.
Journal: Transplantation and cellular therapy
Published: June 04, 2026
Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients.
Journal: Transplantation and cellular therapy
Published: April 20, 2026
Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: April 17, 2026
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee.
Journal: Bone marrow transplantation
Published: April 14, 2026
Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes.
Journal: Transplantation and cellular therapy
Published: March 26, 2026
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.
Journal: American journal of hematology
Published: March 23, 2026
Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Journal: Haematologica
Published: March 11, 2026
Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation.
Journal: Blood advances
Published: March 09, 2026
Absolute Risk Trade-offs of Donor Age, Sex, and Graft Source in PTCy-Based Transplantation.
Journal: Blood advances
Published: March 09, 2026
The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT.
Journal: American journal of hematology
Published: February 27, 2026
Last Updated: 09/26/2026